Berlin, October 2, 2024 – x-cardiac, a frontrunner in AI-based scientific gadgets for the prediction of postoperative considerations after cardiac surgical treatment, is elated to stammer the winning MDR (Clinical Tool Law) certification of its original x-cardiac-platform. This certification introduces an fully original abilities of products offering cutting-edge applied sciences to optimize patient care and security.
The x-cardiac-platform is an innovative tool within the self-discipline of digital biomarkers and is namely designed to amplify patient security and remedy quality in serious eventualities. With the winning MDR certification, the platform fulfills the strictest European requirements for security and performance and thus marks a significant milestone in scientific abilities.
The original product abilities comprises two innovative fade-ins: x-c-bleeding and x-c-renal-ruin. These fade-ins offer unprecedented encourage within the detection and remedy of bleeding and kidney ruin after foremost heart surgical treatment.
“With the new product generation, we can offer completely new possibilities for predicting postoperative complications in everyday clinical practice, which we will now increasingly promote beyond Germany, Austria, and Switzerland, also with sales partners,” says Oliver Höppner, CEO of x-cardiac. “With the x-cardiac platform, we are offering users a powerful medical device that can make a lasting difference in patient care. We are looking forward to the upcoming EACTS Annual Summit 2024 (European Association for Cardio-Thoracic Surgery) from October 10-12 in Lisbon, where we plan to present our new product generation to the professional audience.”
Chief Clinical Officer Prof. Dr. Alexander Meyer on the original product abilities: “The x-cardiac-platform sets new standards in the clinical care of patients by performing local validation of the algorithms for each customer. This enables us to ensure that our solutions are optimally tailored to individual needs and circumstances. Optional fine tuning allows us to customize the models to deliver even more precise results.”
Contact:
Oliver Höppner
x-cardiac GmbH
presse@xcardiac.com
www.xcardiac.com
